Business Israel-based InterCure previews record sales of $31M The firm says it commands 30% of the country's medical cannabis market Nick LabaFebruary 8, 2022
Business Nextleaf ups annual sales to $3.4M but cash reserves run low In December, the firm finished a public offering for proceeds of $3.2 million Nick LabaFebruary 3, 2022
Business High Tide posts audited financials after delay After being hit with impairment charges, the firm posted a Q4 net loss of $4.2M Nick LabaFebruary 2, 2022
Business High Tide pushes annual sales up 118% to $181.1M in fiscal 2021 Due to 'personnel challenges' the firm has yet to finalize its income tax provision, but expects to do so on or by Jan. 31 Nick LabaJanuary 27, 2022
Business Cannara Biotech sales recover slightly to $6.6M in Q1 The firm reported its third-straight quarter of positive adjusted EBITDA Nick LabaJanuary 20, 2022
Business Organigram reports 22% revenue gain for 2nd straight quarter The company will be EBITDA-positive by Q3, CEO says Nick LabaJanuary 11, 2022
Business Tilray ekes out Q2 profit despite 16% drop in pot sales For better or for worse, the firm's focus appears to be moving further away from cannabis sales Nick LabaJanuary 10, 2022
Business Kiaro boosts Q3 sales 23% to $7.5M following acquisitions A recent capital raise has boosted the firm's cash position Nick LabaDecember 17, 2021
Business Hexo’s sales spike 31% with $117M loss after steep impairments in Q1 The company is also making a number of new changes to its top management Nick LabaDecember 14, 2021
Business Flowr Corp posts $9.2M loss in Q3 The firm says opportunities lie in new genetics and its EU GMP-certified operations in Portugal Nick LabaNovember 29, 2021